Malta - angličtina - Medicines Authority

colonis pharma limited quantum house, hobson industrial estate, burnopfield, country, durham ne16 6ea, united kingdom - colecalciferol - hard capsule - colecalciferol 800 iu - vitamins

Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

bio-practica pty ltd - colecalciferol -

Írsko - angličtina - HPRA (Health Products Regulatory Authority)

meda health sales ireland limited - colecalciferol - tablets - 1000 international unit - vitamin a and d, incl. combinations of the two - vitamin supplements - prevention and treatment of vitamin d deficiency in adults and adolescents. vitamin d deficiency is defined as serum levels of 25-hydroxycolecalciferol (25(oh)d) < 25 nmol/l. in addition to specific osteoporosis treatment of patients who are at risk of vitamin d deficiency, preferably in combination with calcium

Írsko - angličtina - HPRA (Health Products Regulatory Authority)

meda health sales ireland limited - colecalciferol - tablets - 2000 international unit - vitamin a and d, incl. combinations of the two - vitamin supplements - treatment of vitamin d deficiency in adults and adolescents. vitamin d deficiency is defined as serum levels of 25-hydroxycolecalciferol (25(oh)d) < 25 nmol/l

Írsko - angličtina - HPRA (Health Products Regulatory Authority)

meda health sales ireland limited - colecalciferol concentrate - tablets - 4000 international unit - vitamin a and d, incl. combinations of the two - vitamin supplements - treatment of vitamin d deficiency in adults and adolescents. vitamin d deficiency is defined as serum levels of 25-hydroxycolecalciferol (25(oh)d) < 25 nmol/l.

Írsko - angličtina - HPRA (Health Products Regulatory Authority)

consilient health limited - colecalciferol - oral solution - 25,000 international unit(s) - vitamin d and analogues; colecalciferol - vitamin d, colecalciferol - the prevention and treatment of vitamin d deficiency. as an adjunct to specific therapy for osteoporosis in patients with vitamin d deficiency or at risk of vitamin d insufficiency

Európska únia - angličtina - EMA (European Medicines Agency)

n.v. organon - colecalciferol, alendronic acid (as sodium trihydrate) - osteoporosis, postmenopausal - drugs for treatment of bone diseases - treatment of postmenopausal osteoporosis in patients at risk of vitamin-d insufficiency.adrovance reduces the risk of vertebral and hip fractures.

Nový Zéland - angličtina - Medsafe (Medicines Safety Authority)

teva pharma (new zealand) limited - alendronate sodium monohydrate 81.2mg equivalent to alendronic acid 70 mg; colecalciferol 0.14mg;   - film coated tablet - active: alendronate sodium monohydrate 81.2mg equivalent to alendronic acid 70 mg colecalciferol 0.14mg   excipient: butylated hydroxytoluene colloidal silicon dioxide copovidone magnesium stearate mannitol medium-chain triglycerides microcrystalline cellulose   opadry white 85f18378 purified water sucrose - indicated for the treatment of osteoporosis in select patients where viatmin d supplementation is recommended.

Nový Zéland - angličtina - Medsafe (Medicines Safety Authority)

teva pharma (new zealand) limited - alendronate sodium monohydrate 81.2mg equivalent to alendronic acid 70 mg; colecalciferol 0.07mg;   - film coated tablet - active: alendronate sodium monohydrate 81.2mg equivalent to alendronic acid 70 mg colecalciferol 0.07mg   excipient: butylated hydroxytoluene colloidal silicon dioxide copovidone magnesium stearate mannitol medium-chain triglycerides microcrystalline cellulose   opadry white 85f18378 purified water sucrose - indicated for the treatment of osteoporosis in select patients where viatmin d supplementation is recommended.

Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

dr reddys laboratories australia pty ltd - alendronate sodium,colecalciferol,calcium carbonate,microcrystalline cellulose -